(Q44021007)

29 November 2017

title

The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors (English)

1 reference

29 November 2017

Hidetoshi Tozaki

1

1 reference

29 November 2017

Akira Matsumoto

2

1 reference

29 November 2017

Takeshi Kanno

3

1 reference

29 November 2017

Kaoru Nagai

4

1 reference

29 November 2017

Tetsu Nagata

5

1 reference

29 November 2017

Satoshi Yamamoto

6

1 reference

29 November 2017

Tomoykui Nishizaki

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Biochemical and Biophysical Research Communications

29 November 2017

published in

1 reference

29 November 2017

volume

294

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

42-45

1 reference

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autobiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

Mechanisms of neuronal degeneration in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

Presynaptic nicotinic ACh receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

Mechanisms Underlying Long-Term Potentiation of Synaptic Transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

Molecular diversity of neuronal nicotinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

beta-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900429-1

10.1016/S0006-291X(02)00429-1

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference